Clinical trial
The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects…
NCT00293176 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00293176 |
|---|---|
| Title | The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI) |
| Official title | A One-Year, Multicenter, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI) |
| Lead sponsor | Eisai Inc., Industry |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Memory Loss |
| Intervention type | Drug |
| Interventions | Donepezil Hydrochloride, Placebo |
| Enrollment | 821 |
| Start date | Dec 1, 2003 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Feb 17, 2006 |
| Last update posted | Apr 1, 2011 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: